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Abstract Cerebral capillaries represent a major interface
between the general circulation and the central nervous
system and are responsible for sufficient and selective nu-
trient transport to the brain. Structural damage or dys-
functioning carrier systems of such an active barrier leads
to compromised nutrient trafficking. Subsequently, a de-
creased nutrient availability in the neural tissue may con-
tribute to hampered neuronal metabolism, hence to behav-
ioral and cognitive functional deficiencies. Here we focus
on the ultrastrucutral abnormalities of cerebral microves-
sels in Alzheimer’s disease (AD; n = 5) and Parkinson’s
diseasse (PD; n = 10). The capillary microanatomy in
samples from the cingulate cortex was investigated by
electron microscopy and severe damage to the vessel
walls was observed. Characteristic pathological changes
including capillary basement membrane thickening and
collagen accumulation in the basement membrane were
enhanced in both AD and PD. The incidence of capillaries
with basement membrane deposits was two times higher
in AD and PD than in age-matched controls. Degenerative
pericytes in all groups appeared at a similar frequency.
The data indicate that basement membrane deposists, as
opposed to pericytic degeneration, represent an important
pathological feature of AD and PD and suggest that capil-
lary dysfunction may play a causal role in the develop-
ment of these two major neurodegenerative diseases.
Key words Alzheimer’s disease · Capillary ultrastruc-
ture · Cerebral hypoperfusion · Parkinson’s disease
Introduction
Morphological abnormalities of cerebral capillaries and
related deficient cerebral circulation observed in demen-
tia, and in Alzheimer’s disease (AD) in particular, have
gained increasing attention in recent years. Investigation
of the influence of altered cerebral circulation and abnor-
mal cerebromicrovascular microanatomy on learning and
memory includes both clinical scanning and postmortem
examinations, as well as experimental animal studies.
Clinical research can highlight important physiological
parameters of the cerebral circulation of patients by the
use of non-invasive scanning. Single photon emission
computed tomography (SPECT) studies demonstrated that
the regional cerebral blood flow of demented subjects was
considerably decreased compared to controls. The reduc-
tion in flow rate was found to be most pronounced in the
hippocampus and temporal cortex, regions which are
known to be first and most severely affected in AD [3, 10,
15, 32]. In addition, the degree of hypoperfusion in the
hippocampus correlated well with the stage of dementia
[32]. The remarkable finding that insufficient cerebral cir-
culation is associated with memory deficits and cognitive
impairment stimulated further research in laboratory ani-
mals. By occluding the carotid arteries, the negative effect
of decreased cerebral blood flow on cognitive processes
was reproduced in rats [9, 13, 34]. The created chronic ex-
perimental cerebral hypoperfusion resulted in impaired
spatial memory of the animals in a water maze paradigm
and the increase of errors in the later phase of learning in
the radial maze spatial memory test, both of which are in-
dicative of hippocampal dysfunction [9, 34].
These data show that a sufficient cerebral perfusion ap-
pears to be essential for proper memory processing. With
a lower perfusion rate, the nutrient transport to the brain
may not be adequate, which may cause hampered neu-
ronal metabolism and consequent cognitive disturbances.
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Indeed, the rate of cerebral metabolisms of oxygen and
glucose and the density of glucose transporter sites in the
cerebral capillary walls were found to be distinctly re-
duced in AD [18, 21–23, 31]. Such deprivation of the neu-
ronal tissue can derive from either the lower flow rate it-
self (implying a reduced volume of blood reaching the
brain capillaries) or the compromised permeability of the
capillary walls due to abnormal structural features [12].
Most probably, the two factors are dynamically and pro-
gressively connected and equally jeopardize nutrient traf-
ficking in the brain.
Cerebral hypoperfusion has been implicated in the de-
velopment of cerebral capillary damage [8, 9] and the
morphological characterization of capillaries in dementia
has also revealed distinctive pathology. Structural damage
to brain microvessels in AD and Pick’s disease was de-
scribed at the light microscopic level as twisting, tortuous
structure, fragmentation and atrophy of capillaries, where-
ase in amyotrophic lateral sclerosis/parkinsonism-demen-
tia complex, mainly severe fragmentation of the vessels
was encountered [5]. The data suggest that, although cap-
illary damage obviously accompanies cognitive deficien-
cies, it is not specific to a particular type of dementia.
Capillary damage would rather appear as a general, de-
mentia-associated pathological property.
The irregular appearance of brain capillaries seen un-
der the light microscope relates to alterations in the mi-
crovessel walls observed by electron microscopy (EM).
EM examination of cerebral microvessels in humans was
mainly restricted to AD where the observed microanatom-
ical irregularities of endothelial cells, capillary basement
membrane (BM) and pericytes were extensively described
[6, 8, 36]. BM pathology can occur in the form of thick-
ening on the abluminal surface of capillaries and is
thought to be the result of either increased secretion or de-
creased turnover of BM components. The abnormal fold-
ing and layering of the BM leads to BM duplication,
while BM splitting creates vacuoles within the BM, often
filled with collagen fibers [24, 36]. Pericytic degeneration
can usually be identified at its earlier stages by inclusion
bodies accumulating in the cytoplasm and a totally disin-
tegrated intracellular structure with the progress of dam-
age [7].
Although the listed abnormalities at the EM level were
reported mainly in AD, the question is raised whether
such microvascular disintegration is a specific feature of
AD or more common to other neurodegenerative diseases,
with particular attention to several types of dementia. Pre-
liminary studies from our lab have already indicated that
cerebrocortical microvessels show BM thickening, vac-
uolization and precytic degradation in clinical Parkinson’s
disease with cortical Lewy bodies (PD) and cerebrovascu-
lar disease (CVD), in addition to AD [8, 17]. Here we pro-
vide an extended overview of the aberrations of cerebral
capillary walls in AD and PD with or without AD-like
neuropathology.
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Case Age Gender Clinical diagnosis BP LB NFT Amyl. CERAD Braak AA Vascular SN
no. (years) score stage factors Pathol
1 67 M Septichaemia 100/60
2 66 M Myocardiac infarct HT
3 64 M Myocardiac infarct HT
4 63 M Myocardiac infarct 160/75
5 78 F Lung cancer 130/75
6 77 M Alzheimer’s 170/80 – +++ +++ Definite V + – –
7 78 F Alzheimer’s 160/90 – +++ +++ Definite V ± ecAS++ –
8 87 F Alzheimer’s 180/85 – ++ +++ Probable IV – – –
9 83 M Alzheimer’s 170/90 – ++ +++ Probable IV + – –
10 85 M Alzheimer’s 150/75 – +++ +++ Definite V + ecAS++ –
11 68 F Parkinson’s 140/70 N – + – III – icAS+ +++
12 76 F Parkinson’s 170/75 L – – – II – – +++
13 77 M Parkinson’s – N – +++ – III – icAS+ +++
14 68 M Parkinson’s 125/85 L + +++ Possible II – – +++
15 85 F Parkinson’s 150/90 B – + – I–II + – +++
16 64 M Parkinson’s 160/60 L – – – 0 – icAS+, micro- +++
infarct BG
17 66 M Parkinson’s 130/70 N + +++ Probable III + – +++
18 70 F Parkinson’s 150/80 N ++ +++ Definite IV + – +++
19 80 F Parkinson’s 175/80 N ++ +++ Probable III + ecAS++, icAS+ +++
20 86 F Parkinson’s 190/95 L + ++ Probable III–IV + – +++
Table 1 Neuropathological characterization of the patients in-
cluded in the study (AA amyloid angiopathy, Amyl cerebral amy-
loid deposits, B brain stem predominant Lewy bodies, BP blood
pressure, HT hypertenison, ecAS extracerebral atherosclerosis,
icAS intracerebral atherosclerosis, L limbic Lewy bodies, LB Lewy
Body, N neocortical Lewy bodies, NFT neurofibrillary tangles, SN
pathol substantia nigra pathology)
Materials and methods
EM investigation was performed on human post-mortem tissue
samples obtained from the cingulate cortex of AD patients (n = 5),
PD patients (n = 6), PD with cerebral pathology of AD (PDd, n =
4), and non-demented age-matched controls (C, n = 5). The com-
position of the four groups is shown in Table 1. The groups ran-
domly consisted of both male and female patients ranging from 63
to 87 years old. The clinical diagnosis of the patients was con-
firmed by routine post-mortem analysis of the brains. The neu-
ropathological examination determined the presence and distribu-
tion of Lewy bodies in the brain stem, limbic regions and the neo-
cortex according to previously defined guidelines [14, 29]. Fur-
thermore, the allocortical spread of neurofibrillary tangles (NFT),
indicating Braak stages, and the distribution of neocortical plaques
in view of the age and clinical history of the patients (CERAD
scale) were carefully evaluated [3, 30]. The experimental groups
were formed based on the assessed neuropathological data.
Samples were collected at autopsy in Karnovsky fixative (2%
glutaraldehyde and 1% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4) and transferred to fresh solution prior to EM. Tis-
sue blocks were cut into 50-µm sections with a vibratome and rou-
tinely embedded in glycine ethylether. Samples covering the entire
cortical depth were embedded and were cut to semithin thickness
followed by azur and methylene blue staining for layer orientation.
Non-serial, ultrathin sections were collected on 200-mesh copper
grids and were contrasted with 5% aqueous uranyl acetate and
Reynold’s lead solution. Cortical capillaries were examined with a
Philips 201 electron microscope.
The quantitative method used here was previously established
in rat and human brain material, and has proved to be an effective
approach for evaluating capillary wall alterations as a result of ag-
ing and cerebral hypoperfusion [7–9]. The advantage of the
method is that it screens systematically the entire depth of the cor-
tex covering all the cortical layers and counting every capillary en-
countered. Moreover, a high number of microvessels can be inves-
tigated to present a general overview of capillary ultrastructure.
Approximately 100 capillaries per case were screened throughout
the cortical layers focusing on the BM and pericyte pathology as
defined below. The analysis was performed blind by two inde-
pendent investigators. The number of vessels with aberrations was
counted directly on the screen of the electron microscope. Only
transversely cut microvessels were analyzed and capillaries par-
tially covered by the mesh of the carrying grid were disregarded.
The following categories of capillary abnormalities were distin-
guished based on previously accepted and detailed conditions
[7–9]:
1. Local BM thickening (BMT, Fig.1B). This was defined as the
BM showing local thickening if the luminal and abluminal outline
of the BM were not running parallel, as shown in Fig.1B. Regions
of the BM where the BM splits to embrace pericytes were not con-
sidered because the BM appears usually thicker at such segments.
In case of the presence of an embedded pericyte, only the outer
BM was investigated, the layer separating the endothelial cell and
the pericyte was not. Random, irregular branching and folding of
the BM (Fig.1C) were also considered as BMT. BMT was also de-
termined according to the following measurements: EM pho-
tographs of deformed microvessels were randomly taken and the
width of the BM was measured at a segment with regular thickness
and at a visibly enlarged part of the same vessel. The assessed val-
ues for a healthy segment ranged between 126–323 nm, while
thickening was indicated between 253–843 nm. The BM was con-
sidered to feature BMT when the measured thickness at the en-
larged part was at least two times wider than that assessed at the
unaffected segment of the same capillary. The method was rou-
tinely applied on the EM screen.
2. Fibrosis (Fig.1D). The term refers to excessive collagen type
IV accumulation between two layers of the BM, identified by its
typical periodicity, or collagen invasion to the vascular cells from
a split BM (see Fig.3C, D). When a capillary demonstrated both
BMT and fibrosis, fibrosis overruled BMT and the capillary was
counted only as one with fibrosis.
3. Degenerative pericytes (Fig. 1 E). These showed abnormal, frac-
tional inclusion bodies or swelling. Lipofuscin granules in the per-
icytic cytoplasm were not regarded as aberrant features. The term
“deposits” was applied to the merged group of BMT and fibrosis,
and “capillary aberrations” for the combination of deposits and de-
generative pericytes.
After counting the absolute number of vessels per category, the
amount of damaged microvessels was expressed as percentages of
the total number of capillaries encountered for each class of vascu-
lar pathology. The data was statistically analyzed with the non-
parametric Mann-Whitney-U test to define significance values
(significance was taken as P ≤ 0.05).
Results
The ultrastructural abnormalities of cerebral capillaries
were examined in post-mortem cingulate cortex samples
of three groups of neurological patients. BM deposits
(BMT and fibrosis) and pericytic degeneration of AD, PD
and PDd cases were compared to those of age-matched
controls. Linear correlation between age and the ratio of
abnormal capillaries could not be observed. The data of
individual cases are summarized in Tables 2 and 3.
Figure 3B demonstrates typical BMT of an AD patient
compared to a normal, control BM (Fig.3A). The ratio of
microvessels with BMT was doubled in the three patho-
logical groups compared to controls, reaching significant
values (Fig.2A). A representative example of extensive
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Fig.1A–E Schematic drawings representing categories of capil-
lary wall pathology. A A healthy capillary. B Basement membrane
thickening pointed at by arrows. C Abnormal duplication and
branching of the basement membrane. D Fibrosis. E Pericytic de-
generation (L capillary lumen, E endothelial cell, N endothelial nu-
cleus, P pericyte, * basement membrane)
fibrosis is shown in Fig.3C and D. The ratio of vessels
with such collagen accumulation remarkably increased in
AD, PD and PDd but showed considerable variance among
individual cases (Fig.2B). The combination of BMT and
fibrosis, defined as deposits in the capillary walls may
provide a more objective approach to describe BM pathol-
ogy, as the two features are considered to be progressively
related. Deposits in the BM exhibited a remarkable and
significant increase in AD, PD and PDd, as shown in 
Fig.2C. The number of capillaries with deposits in these
three groups was more than two times higher than that of
controls. On the other hand, degenerative pericytes were
encountered to a similar proportion in all groups including
the controls, suggesting no specific involvement of peri-
cytic degradation in any of the studied neurological con-
ditions (Fig.2D). An example of a degenerative pericyte
is shown in Fig.3E.
In general, the cerebral capillaries of AD, PD and PDd
patients were affected, and demonstrated specific BM
pathology. Disease-related vascular damage was restricted
to the BM and did not involve the pericytes. Deposits in
the capillary walls, as well as BMT were highest in the
PDd group, although this group did not differ significantly
from either the AD or the PD patients.
The control group that we assembled was not strictly
age-matched due to limitations at performing autopsy.
However, all cases exceeded the age of 60 years and were
considered aged. A correlation analysis was performed to
rule out that the vascular aberrations observed here pre-
sent an age-related phenomenon: no significant correla-
tion could be seen between the age of the patients and any
of the defined categories of cerebral capillary damage.
Fig.4 shows a representative correlation graph concerning
the percentage of intact capillaries.
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Table 2 Summary of the indi-
vidual data of control cases
and AD patients. (AD Alzhei-
mer’s disease, deg degenera-
tion, BMT basement membrane
thickening)
*P ≤ 0.05
Case no. Group Gender Age BMT (%) Fibrosis Deposits Pericytic
(%) (%) deg.(%)
1 Control M 67 3.00 1.00 4.00 41.00
2 Control M 66 13.25 0.00 13.25 32.53
3 Control M 64 7.29 5.21 11.46 26.04
4 Control M 63 8.13 17.89 26.02 26.02
5 Control F 78 12.00 5.00 17.00 60.00
Mean 67 8.73 5.82 14.35 37.12
SEM 1.82 3.19 3.60 6.35
6 AD M 77 15.96 4.26 20.21 12.77
7 AD F 78 36.36 10.23 46.59 11.36
8 AD F 87 10.64 5.32 15.96 68.09
9 AD M 83 14.95 16.82 31.77 7.48
10 AD M 85 14.29 30.25 44.54 33.61
Mean 82 18.44 13.38 31.81 26.66
SEM 4.57 4.77 6.19 11.31
P 0.028* 0.175 0.047* 0.347
Table 3 Summary of the indi-
vidual data of PD cases with or
without dementia (PD Parkin-
son’s disease, dem dementia)
* P ≤ 0.05
Case no Group Gender Age BMT (%) Fibrosis Deposits Pericytic
(%) (%) deg. (%)
11 PD F 68 16.13 8.60 24.73 54.84
12 PD F 76 16.09 2.30 18.39 4.60
13 PD M 77 29.41 2.94 32.35 26.47
14 PD M 68 3.64 34.55 38.18 28.18
15 PD F 85 24.66 8.90 33.56 42.47
16 PD M 64 20.41 11.22 31.63 22.45
Mean 73 18.39 11.42 29.76 29.84
SEM 3.62 4.85 2.88 7.05
P 0.045* 0.273 0.018* 0.584
17 PD + dem. M 66 13.83 6.83 20.21 63.83
18 PD + dem. F 70 30.77 19.23 50.00 5.77
19 PD + dem. F 80 24.49 0.00 24.49 38.78
20 PD + dem. F 86 16.19 25.71 41.90 24.76
Mean 75.5 21.32 12.83 34.15 33.29
SEM 3.89 5.87 7.06 12.22
P 0.014* 0.268 0.050* 0.624
Discussion
We have shown in the present study that the capillary ul-
trastructure in the limbic cingulate cortex of AD, PD and
PDd patients is severely compromised. In addition to de-
mentia-related disorders, PD is also shown here to be sub-
ject to cerebrovascular microanatomical alterations, par-
ticularly BM depositions. The cingulate cortex proves to
be a proper area for investigation because neuropatholog-
ical alterations characteristic of AD or PD, namely neu-
ritic plaques, NFT or Lewy bodies, can be all observed in
the region. The spread of NFT, an accepted marker for the
pathological staging of AD, covers the complete limbic
cortex with the progression of the disease and affects the
entire isocortex at the later stages [3]. The appearance of
Lewy bodies, the cortical lesion that can accompany PD,
concerns the cingulate gyrus, as well [4].
Research on capillary anatomy and cortical regional
cerebral perfusion rate has chiefly focused on their rela-
tionship with dementia; therefore, information about the
phenomenon in other human neurological disorders is rel-
atively scarce. However, PET studies showed decreased
regional cerebral blood flow (rCBF) and oxygen utiliza-
tion in PD [28]. Moreover, Kawabata et al. [27] conducted
SPECT examinations and found that the rCBF of PD sub-
jects with or without dementia was significantly reduced
in the temporal and parietal cortices or the frontal and
temporal cortices, respectively. Varma et al. [42] also
showed cortical blood flow alterations in PD with demen-
tia. The described observations appear to be rather similar
to AD in that the temporal, parietal and frontal cortical
lobes are primarily affected [10, 15, 32].
To place our pathological results into a physiological
context and to be able to hypothesize cause-effect rela-
tionships, experimental animal studies are needed. Bilat-
eral, chronic carotid artery occlusion in rats (2VO) has
proved to be a cerebral hypoperfusion model that creates
dementia-like symptoms such as learning impairment and
memory deficits. Besides the typical spatial memory
deficits demonstrated by water maze and radial maze
tasks in 2VO rats [9, 34], sypmtoms of progressive neu-
rodegeneration similar to that seen in human dementia
have also been observed, such as characteristic apoptotic
pyramidal cell damage in the hippocampus CA1, the pri-
mary site of neuropathological changes in AD [1, 3, 13].
Furthermore, additional features of AD, such as increased
immunoreaction to glial fibrillary acidic protein and amy-
loid precursor protein accumulation, were reported after
2VO [13, 25]. The described hypoperfusion-related cog-
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Fig.2 Ultrastructural BM ab-
normalities in neurological dis-
orders compared to controls. 
* ≤ 0.05 (AD Alzheimer’s dis-
ease, PD clinical Parkinson’s
disease with cortical Lewy




nitive malfunction was also accompanied by cerebral cap-
illary damage as demonstrated by De Jong et al. [8, 9].
Considering all these the experimental data, a group of
properties reminiscent of particular aspects of AD is as-
sembled [11]. Therefore, it is tempting to speculate that
the ultrastructural capillary abnormalities in human sam-
ples presented here and previously by others [6, 8, 36] are
most likely associated with chronic cerebral hypoperfu-
sion. Since cerebral hypoperfusion in animals causes mas-
sive capillary damage in the brain [8, 9], the alterations in
rCBF possibly act as a causal factor inducing microvessel
malformations not only in AD but also in PD and PD with
dementia.
Morphological capillary abnormalities can not only be
linked to cerebral hypoperfusion but may also account for
compromised metabolic rates in the neural tissue. Re-
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Fig.3A–E Photomicrographs demonstrating illustrative patho-
logical ultrastructural alterations of human cerebral capillary
walls. The BM in each photograph is indicated by arrowheads. 
A A healthy capillary of a control sample. B BM thickening of an
AD patient. C Transversely cut collagen bundles invading the per-
icytic cytoplasm. D BM duplication with transversely cut collagen
fibers. E A swollen, degenerating pericyte with inclusion bodies 
in the cytoplasm (er erythrocyte in the capillary lumen, e endothe-
lial cytoplasm, en endothelial nucleus, p pericyte). A × 36,000; 
B × 26,5000: C × 54,5000; D × 48,000; E × 12,500
duced glucose metabolism in AD brains is a well-estab-
lished phenomenon [2, 37]. Although the existence of re-
duced glucose metabolism in PD is a topic of debate, and
contradicting PET results are available [16, 35, 38], PD
with dementia has consistently been shown to be accom-
panied by reduced cerebral glucose metabolism [35, 38,
41]. A lower metabolic rate for glucose may be caused by
hypoglycemia (resulting from the above-described hypo-
perfusion) or defective transport through distorted capil-
lary walls. Both the physical features of capillaries, such
as BMT shown here, and the functional damage to endo-
thelial transport molecules can explain the latter possibil-
ity. Glucose transporters of the endothelial cells (GLUT-
1) suffer dramatic changes in AD, as indicated by the
lower level of GLUT-1 in the cerebral cortex [21, 22, 31],
but GLUT-1 density measurements in PD have, to our
best knowledge, not yet been reported.
Microvascular atrophy can be evoked not only by cere-
bral hypoperfusion but also by compromised metabolic
routes of microvascular cells. The components of the cap-
illary BM (collagen type IV, laminin and heparan sulfate
proteoglycan) are secreted by the three cell types of the
microvessels: the endothelial cells, the pericytes and the
astrocytes [44]. Perlmutter and Chui [36] suggested that
the production of these molecules may be under the influ-
ence of toxic external stimuli. Prominent examples are 
β-amyloid action on endothelial cells leading to endothe-
lial dysfunction [39, 40] or the effect of oxygen free radi-
cals on endothelial cells causing chromosomal aberrations
and the induction of micronuclei [26]. Thus, the effect of
β-amyloid or oxidative stress can alter the internal metab-
olism of the endothelial cells, which may imply, among
others, a corrupt production of BM constituents. Oxida-
tive stress is considered to be a contributing factor in the
development of both AD and PD [19, 20, 33]. In addition
to inducing neuronal damage, accumulating oxygen radi-
cals may interfere with capillary ultrastructure by express-
ing a toxic influence on endothelial metabolism in AD
and PD.
We found that capillaries with deposits occurred con-
siderably more frequently in AD, PD and PDd than in
controls, but the incidence of degenerating pericytes was
not disease specific. Our data for pericytes do not agree
with those of previous reports describing AD-associated,
β-amyloid-induced damage to pericytes in cell culture
[43]. The source of this discrepancy may lie in the
methodological approach, although our theory that the
presence of degenerating pericytes does not relate to de-
mentia is supported by the lack of correlation between ex-
isting pericytic degeneration and learning performance in
rats [9]. Thus, BM deposits, rather than pericytic irregu-
larities, represent a crucial microvascular pathological
property in neurological disorders.
We conclude that in addition to the neural tissue, the
cerebral capillary network is also prone to structural
degradation under neurological conditions like AD, PD
and PDd. The microvascular BM suffers the most pro-
nounced and dramatic damage as opossed to pericytes and
emerges as a central target of vascular pathological changes
in these disorders. The described structural BM malfor-
mations can lead to pathophysiological consequences
such as compromised nutrient transport, insufficient neu-
ronal metabolism and subsequent cognitive disturbances.
Because of the multiple consequences, cerebral capillary
damage must be considered a significant property or con-
tributing factor in the development of AD, and possibly
PD.
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